|Q -- USA Stock|| |
USD 103.48 0.57 0.55%
Mr. Ari Bousbib is a Chairman of the Board, President, Chief Executive Officer of the Company. He assumed this position in October 2016 following the Merger of Quintiles and IMS Health. From 2010 until the Merger, Mr. Bousbib served as chairman and CEO of IMS Health. In 2014, he led the successful IPO of the company. Prior to joining IMS Health, Mr. Bousbib spent 14 years at United Technologies Corporationrationration, an aerospace, defense and building industries company. From 2008 until 2010, he served as President of UTCs Commercial Companies, including Otis Elevator Company, Carrier Corporationrationration, UTC Fire Security and UTC Power Inc. From 2002 until 2008, Mr. Bousbib was President of Otis, and from 2000 to 2002 he served as its Chief Operating Officer. Previously, Mr. Bousbib was a partner at Booz Allen Hamilton. Mr. Bousbib currently serves on the board of directors of The Home Depot, Inc. and is a member of the Harvard Medical School Health Care Policy Advisory Council. He previously served on the board of directors of Best Buy, Inc. and was appointed by the President of the United States to serve on the Presidents Commission on White House Fellowships
Age: 55 Director Since 2016 MBA
Bousbib holds a MS Degree in Mathematics and Mechanical Engineering from the Ecole Superieure des Travaux Publics, Paris, and an M.B.A. from Columbia University.
Ari Bousbib Latest Insider Activity
The company has return on total asset of 4.03 %
which means that for every 100 dollars spent on asset it generated profit of $4.03. This is acceptable considering the industry classification. Similarly, it shows return on equity (ROE)
of 1.89 %
implying that it made 1.89 on every $100 invested by shareholders.
The company has accumulated 9.77 B in total debt with debt to equity ratio (D/E) of 130.0 implying that the company may be unable to produce cash to meet its debt commitments. IQVIA Holdings has Current Ratio of 1.2 implying that it may have difficulties to pay its interest payments when they become due.
Quintiles IMS Holdings, Inc. offer biopharmaceutical development services and commercial outsourcing services in the Americas, Europe, Africa, and the AsiaPacific. IQVIA Holdings (Q) is traded on New York Stock Exchange in USA. It is located in 4820 Emperor Blvd., Durham, NC 27703, United States and employs 36,100 people.
IQVIA Holdings Leadership Team
|Thomas Pike, CEO|
|Ari Bousbib, Director, MBA|
|Michael Evanisko, Director|
|Leonard Schaeffer, Director|
|James Erlinger, President, MBA|
|John Danhakl, Director, MBA|
|Richard Staub, President|
|Michael McDonnell, President|
|Kevin Gordon, COO|
|John Leonard, Director, Ph.D|
|James Fasano, Director, MBA|
|Jonathan Coslet, Director, MBA|
|John Connaughton, Director, MBA|
|Haiyuan Lo, Director|
|Ronald Rittenmeyer, Director, MBA|
|Dennis Gillings, Chairman, Ph.D|
|Todd Sisitsky, Director, MBA|
|Jack Greenberg, Director, CPA|
|Kevin Knightly, President|
Stock Performance Indicators